Latest Aptose Biosciences News: View APTO news and discuss market sentiment with the investor community on lor-center74.ru Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs. Aptose Biosciences Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. Aptose Biosciences Inc. · AT CLOSE PM EDT 07/22/24 · USD · % · Volume95, Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology, with a particular.
Get Aptose Biosciences Inc (APTO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Aptose Biosciences Inc. (US:APTO) has 27 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers. Aptose Biosciences Stock forecast & analyst price target predictions based on 1 analysts offering months price targets for APS in the last 3 months. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Track Aptose Biosciences Inc (APTO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get. Aptose Biosciences has % upside potential, based on the analysts' average price target. Aptose Biosciences Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · APTO Overview · Key Data · Performance · Analyst Ratings. Sell. Find the latest Aptose Biosciences Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Aptose Biosciences Inc Stock Price (APTO). Aptose Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APTO. The last.
On Monday 06/24/ the closing price of the Aptose Biosciences Inc Registered Shs share was $ on BTT. Compared to the opening price on Monday 06/24/ Find the latest Aptose Biosciences Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. Aptose Biosciences Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range - 52 Wk Range - Morningstar Financial Research conducts Analysis on Markets, Mutual Fund, Stocks and ETFs through Investment Data and News. Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies that address unmet medical needs in oncology in. Aptose Biosciences Inc APTO:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/05/23 · 52 Week Low. Investors · NASDAQ: APTO · TSX: APS · Analyst Coverage · SEC Filings · Overview · All SEC Filings · Annual Reports · Quarterly Reports · Section 16 Filings. Adicet Bio Inc. $ ACET % ; BioXcel Therapeutics Inc. $ BTAI % ; aTyr Pharma Inc. $ ATYR % ; Tonix Pharmaceuticals Holding Corp. $
APTO / Aptose Biosciences Inc. (NasdaqCM) - Forecast, Price Target, Estimates, Predictions. Aptose Biosciences Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · APTO Overview · Key Data · Performance · Analyst Ratings. Sell. Why Aptose Biosciences Shares Are Jumping Today Investors excited about the biotech's prospects are taking the opportunity to buy on the dip following the. APTO stock price. How has the Aptose Biosciences stock price performed over time. Intraday. %. 1 week. %. 1 month. %. 1 year. %. YTD. Get Aptose Biosciences Inc. (APTO) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding.
Aptose Biosciences Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range - 52 Wk Range - See the latest Aptose Biosciences Inc stock price (APTO:XNAS), related news, valuation, dividends and more to help you make your investing decisions. The average one-year price target for Aptose Biosciences Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target. Stock Data Aptose Biosciences Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Aptose. Latest Aptose Biosciences News: View APTO news and discuss market sentiment with the investor community on lor-center74.ru Company Profile. Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology. Over the last year, Aptose Biosciences shares have traded in a share price range of $ to $ Aptose Biosciences currently has 20,, shares. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. ALX Oncology Holdings Inc. $ ALXO ; Apollomics Inc. $ APLM ; AbCellera Biologics Inc. $ ABCL ; Amarin Corporation plc. $ AMRN ; Atlasclear. Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers. Aptose Biosciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. APTO updated stock price target summary. Stock analysis for Aptose Biosciences Inc (LTI:Stuttgart) including stock price, stock chart, company news, key statistics, fundamentals and company. Real-time Price Updates for Aptose Biosciences Inc (APS-T), along with buy or sell indicators, analysis, charts, historical performance, news and more. APTO Stock Performance ; Previous close, ; Day range, - ; Year range, 0 - 3 ; Market cap, 6,, ; Primary exchange, NASDAQ. About Aptose Biosciences (APTO) ; Price / earnings ratio. x ; Yesterday's range. $ - $ ; Debt / equity. — ; 52 week range. $ - $ ; 5 year debt /. Aptose Biosciences, Inc. (NASDAQ: APTO, TSX: APS) is a clinical-stage biotechnology company dedicated to developing precision medicines for the treatment of. Aptose Biosciences Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs. Aptose Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of. Aptose Biosciences Inc (APTO) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Aptose Biosciences Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. Get Aptose Biosciences Inc. (APTO) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding. Track Aptose Biosciences Inc (APTO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get. Get the latest stock price for Aptose Biosciences Inc. (APS), plus the latest news, recent trades, charting, insider activity, and analyst ratings. The average price target for Aptose Biosciences is $ This is based on 1 Wall Streets Analysts month price targets, issued in the past 3 months. Aptose Biosciences Inc. (US:APTO) has 27 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Why Aptose Biosciences Shares Are Jumping Today Investors excited about the biotech's prospects are taking the opportunity to buy on the dip following the. Discover real-time Aptose Biosciences, Inc. Common Shares (APTO) stock prices, quotes, historical data, news, and Insights for informed trading and. Aptose Biosciences (APTO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Stock Quote Aptose Biosciences Inc. NASDAQ Capital Market: APTO Created with Highstock FrequencyM.
Aptose Biosciences (APTO) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge. In depth view into APTO (Aptose Biosciences) stock including the latest price, news, dividend history, earnings information and financials.